Shanghai and Shenzhen Exchanges Add COFOE MEDICAL and WELLCELL HOLD to Southbound Trading Eligibility
Stock News
Yesterday
The Shanghai and Shenzhen stock exchanges have separately announced that, in accordance with the respective implementation rules for the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, COFOE MEDICAL (01187) and WELLCELL HOLD (02477) will be added to the list of securities eligible for the Southbound Trading Channel. The inclusion of COFOE MEDICAL is due to its listing on The Stock Exchange of Hong Kong Ltd not being subject to a price stabilization mechanism and the corresponding A-shares having been listed for over 10 trading days. The inclusion of WELLCELL HOLD follows the commencement of parallel trading for its spin-off shares. The changes will take effect starting May 6, 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.